DC-based vaccines gaining ground

Article

Tampa, Fla. — Although development of melanoma vaccines based on dendritic cells (DCs) lags behind that of more established approaches, it's rapidly moving from the lab bench into clinical trials.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.